Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Dare Bioscience (DARE) Return on Capital Employed (2017 - 2025)

Dare Bioscience's Return on Capital Employed history spans 7 years, with the latest figure at 1.71% for Q4 2025.

  • For Q4 2025, Return on Capital Employed fell 1701.0% year-over-year to 1.71%; the TTM value through Dec 2025 reached 1.71%, down 1701.0%, while the annual FY2025 figure was 3.76%, 29458.0% up from the prior year.
  • Return on Capital Employed reached 1.71% in Q4 2025 per DARE's latest filing, up from 26.97% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 49.49% in Q1 2024 to a low of 26.97% in Q3 2025.
  • Average Return on Capital Employed over 5 years is 0.97%, with a median of 1.87% recorded in 2022.
  • The largest YoY upside for Return on Capital Employed was 13167bps in 2021 against a maximum downside of -50504bps in 2021.
  • A 5-year view of Return on Capital Employed shows it stood at 1.08% in 2021, then tumbled by -88bps to 2.03% in 2022, then crashed by -468bps to 11.51% in 2023, then skyrocketed by 233bps to 15.3% in 2024, then tumbled by -111bps to 1.71% in 2025.
  • Per Business Quant, the three most recent readings for DARE's Return on Capital Employed are 1.71% (Q4 2025), 26.97% (Q3 2025), and 5.4% (Q2 2025).